[Federal Register Volume 70, Number 63 (Monday, April 4, 2005)]
[Notices]
[Page 17101]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-6632]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Diseases; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Arthritis and 
Musculoskeletal and Skin Diseases Special Emphasis Panel. To review 
NIH Clinical Trial Planning Grant Program (R34s).
    Date: April 29, 2005.
    Time: 10 a.m. to 12:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: NIH-NIAMS Institute, One Democracy Plaza, 6701 Democracy 
Boulevard, Bethesda, MD 20814, (telephone conference call).
    Contact Person: Yan Z. Wange, PhD, Scientific Review 
Administrator, National Institute of Arthritis and Musculoskeletal 
and Skin Diseases, 6701 Democracy Blvd., Suite 820, Bethesda, MD 
20892, (301) 594-4957.

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, 
Arthritis, Musculoskeletal and Skin Diseases Research, National 
Institutes of Health, HHS)

LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-6632 Filed 4-1-05; 8:45 am]
BILLING CODE 4140-01-M